These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 29607307)

  • 1. Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review.
    Daher S; Massarwa M; Benson AA; Khoury T
    J Clin Transl Hepatol; 2018 Mar; 6(1):69-78. PubMed ID: 29607307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Auricularia auricula increases an apoptosis in human hepatocellular carcinoma cells via a regulation of the peroxiredoxin1.
    Kang MA; Jeon YK; Nam MJ
    J Food Biochem; 2020 Oct; 44(10):e13373. PubMed ID: 32743825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in multidisciplinary management of hepatocellular carcinoma.
    Gomaa AI; Waked I
    World J Hepatol; 2015 Apr; 7(4):673-87. PubMed ID: 25866604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical resection for hepatocellular carcinoma with portal vein tumor thrombus in the Asia-Pacific region beyond the Barcelona Clinic Liver Cancer treatment algorithms: a review and update.
    Ye JZ; Wang YY; Bai T; Chen J; Xiang BD; Wu FX; Li LQ
    Oncotarget; 2017 Nov; 8(54):93258-93278. PubMed ID: 29190996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Concise Review on Current Trends in Imaging and Surgical Management of Hepatocellular Carcinoma.
    Asemota J; Saleh M; Igbinovia O; Burns D
    Cureus; 2020 Jul; 12(7):e9191. PubMed ID: 32818122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic therapies for hepatocellular carcinoma.
    Ge S; Huang D
    Drug Discov Ther; 2015 Oct; 9(5):352-62. PubMed ID: 26632544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Goals and targets for personalized therapy for HCC.
    Couri T; Pillai A
    Hepatol Int; 2019 Mar; 13(2):125-137. PubMed ID: 30600478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma.
    De Mattia E; Cecchin E; Guardascione M; Foltran L; Di Raimo T; Angelini F; D'Andrea M; Toffoli G
    World J Gastroenterol; 2019 Aug; 25(29):3870-3896. PubMed ID: 31413525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current management of patients with hepatocellular carcinoma.
    Kanda T; Ogasawara S; Chiba T; Haga Y; Omata M; Yokosuka O
    World J Hepatol; 2015 Jul; 7(15):1913-20. PubMed ID: 26244066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the insulin-like growth factor pathway in hepatocellular carcinoma.
    Enguita-Germán M; Fortes P
    World J Hepatol; 2014 Oct; 6(10):716-37. PubMed ID: 25349643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.
    Eggert T; Greten TF
    Digestion; 2017; 96(1):1-4. PubMed ID: 28605745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Insight and judgment on recurrence of hepatocellular carcinoma after liver transplantation].
    Zheng H; Zhang HM; Zheng WP
    Zhonghua Gan Zang Bing Za Zhi; 2018 Feb; 26(2):88-92. PubMed ID: 29804372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single administration of Selective Internal Radiation Therapy versus continuous treatment with sorafeNIB in locally advanced hepatocellular carcinoma (SIRveNIB): study protocol for a phase iii randomized controlled trial.
    Gandhi M; Choo SP; Thng CH; Tan SB; Low AS; Cheow PC; Goh AS; Tay KH; Lo RH; Goh BK; Wong JS; Ng DC; Soo KC; Liew WM; Chow PK;
    BMC Cancer; 2016 Nov; 16(1):856. PubMed ID: 27821083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.
    Wang EA; Stein JP; Bellavia RJ; Broadwell SR
    Int J Clin Pract; 2017 Nov; 71(11):. PubMed ID: 28758319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma.
    Wang CH; Wey KC; Mo LR; Chang KK; Lin RC; Kuo JJ
    Asian Pac J Cancer Prev; 2015; 16(9):3595-604. PubMed ID: 25987009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic therapy for hepatocellular carcinoma (HCC): from bench to bedside.
    Abdel-Rahman O
    J Egypt Natl Canc Inst; 2013 Dec; 25(4):165-71. PubMed ID: 24207088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioembolisation with yttrium‒90 microspheres versus sorafenib for treatment of advanced hepatocellular carcinoma (SARAH): study protocol for a randomised controlled trial.
    Vilgrain V; Abdel-Rehim M; Sibert A; Ronot M; Lebtahi R; Castéra L; Chatellier G;
    Trials; 2014 Dec; 15():474. PubMed ID: 25472660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Status of Gene Therapy in Hepatocellular Carcinoma.
    Reghupaty SC; Sarkar D
    Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31466358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances and Future Directions in the Treatment of Hepatocellular Carcinoma.
    Gosalia AJ; Martin P; Jones PD
    Gastroenterol Hepatol (N Y); 2017 Jul; 13(7):398-410. PubMed ID: 28867968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic therapy for hepatocellular carcinoma: beyond sorafenib.
    Boland P; Wu J
    Chin Clin Oncol; 2018 Oct; 7(5):50. PubMed ID: 30395717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.